EyePoint Pharmaceuticals, Inc. Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $303K, a 189% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Depreciation for 2023 was $464K, a 17.2% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Depreciation for 2022 was $396K, a 27.3% increase from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Depreciation for 2021 was $311K, a 64.6% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $464K +$68K +17.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $396K +$85K +27.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $311K +$122K +64.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $189K +$45K +31.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $144K -$23K -13.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $167K +$76K +83.5% Jul 1, 2017 Jun 30, 2018 10-K 2020-03-16
2017 $91K -$61K -40.1% Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 $152K +$40K +35.7% Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2015 $112K -$27K -19.4% Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 $139K -$86K -38.2% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 $225K +$35K +18.4% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 $190K +$137K +258% Jul 1, 2011 Jun 30, 2012 10-K 2014-09-11
2011 $53K +$16K +43.2% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 $37K Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.